血清PDGF与子宫下段肌壁厚度对瘢痕子宫再次妊娠分娩结局的预测价值

doi:10.11958/20260115

天津医药 ›› 2026, Vol. 54 ›› Issue (7): 760-764.doi: 10.11958/20260115

血清PDGF与子宫下段肌壁厚度对瘢痕子宫再次妊娠分娩结局的预测价值

吴杰(), 姬冰瑞, 郭瑞霞()

郑州大学第一附属医院妇产科（邮编450052）

收稿日期:2026-01-08 修回日期:2026-03-11 出版日期:2026-07-15 发布日期:2026-07-13
通讯作者: ^△E-mail：guoruixiawujie@163.com
作者简介:吴杰（1989），女，主治医师，主要从事产科合并症及并发症方面研究。E-mail：wujiezzu@163.com
基金资助:
河南省医学科技攻关项目(SBGJ202302074)

Predictive value of platelet-derived growth factor and lower uterine segment thickness for delivery outcome in pregnancy with a scarred uterus

WU Jie(), JI Bingrui, GUO Ruixia()

Department of Obstetrics and Gynecology, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China

Received:2026-01-08 Revised:2026-03-11 Published:2026-07-15 Online:2026-07-13
Contact: ^△E-mail：guoruixiawujie@163.com

吴杰, 姬冰瑞, 郭瑞霞. 血清PDGF与子宫下段肌壁厚度对瘢痕子宫再次妊娠分娩结局的预测价值[J]. 天津医药, 2026, 54(7): 760-764.

WU Jie, JI Bingrui, GUO Ruixia. Predictive value of platelet-derived growth factor and lower uterine segment thickness for delivery outcome in pregnancy with a scarred uterus[J]. Tianjin Medical Journal, 2026, 54(7): 760-764.

摘要/Abstract

摘要：

目的探讨瘢痕子宫再次妊娠产妇血小板衍生生长因子（PDGF）、子宫下段肌壁厚度与分娩结局的关系。方法回顾性选取2023年10月—2024年10月于郑州大学第一附属医院分娩的196例瘢痕子宫再次妊娠产妇为研究对象，通过病历系统回顾性收集临床资料；于分娩前采集静脉血，采用酶联免疫吸附试验检测血清PDGF水平；于分娩前经腹部超声测量子宫下段最薄处肌壁厚度。根据分娩结局将其分为结局良好组（132例）和结局不良组（64例）。多因素Logistic回归分析影响瘢痕子宫再次妊娠产妇分娩结局的因素，受试者工作特征（ROC）曲线分析PDGF、子宫下段肌壁厚度预测瘢痕子宫再次妊娠产妇分娩结局的价值。结果结局不良组的年龄、孕期体质量增加量均高于结局良好组，距上次剖宫产时间、分娩孕周均低于结局良好组（均P<0.05）。结局不良组的PDGF水平高于结局良好组，而子宫下段肌壁厚度低于结局良好组（均P<0.05）。Logistic回归分析结果显示，年龄大、孕期体质量增加量大、PDGF升高是瘢痕子宫再次妊娠产妇分娩不良结局的独立危险因素，子宫下段肌壁厚度增加是其保护因素（均P<0.05）。ROC曲线分析结果显示，PDGF、子宫下段肌壁厚度及二者联合预测瘢痕子宫再次妊娠产妇分娩结局的曲线下面积（AUC）分别为0.694（95%CI：0.586~0.802）、0.705（95%CI：0.604~0.807）、0.893（95%CI：0.827~0.959），二者联合预测的AUC均高于单独指标预测（P<0.05）。结论 PDGF水平升高是瘢痕子宫再次妊娠产妇分娩不良结局的危险因素，子宫下段肌壁厚度增加是其保护因素，二者联合预测瘢痕子宫再次妊娠产妇分娩结局具有较好的预测价值。

关键词: 瘢痕, 子宫, 分娩, 受体, 血小板源生长因子, 子宫下段肌壁厚度

Abstract:

Objective To explore the relationship between platelet-derived growth factor (PDGF), thickness of the lower uterine muscle wall and the delivery outcome in pregnant women with a scarred uterus. Methods A retrospective study was conducted on 196 pregnant women with scarred uterus who delivered at the First Affiliated Hospital of Zhengzhou University from October 2023 to October 2024. Clinical data were retrospectively collected through the medical record system. Venous blood sample was collected before delivery, and the serum PDGF level was detected by enzyme-linked immunosorbent assay. The thickness of the muscle wall at the thinnest part of the lower uterine segment was measured by abdominal ultrasound before delivery. Patients were divided into the good outcome group (n=132) and the poor outcome group (n=64) according to the delivery outcome. Multivariate Logistic regression analysis was conducted to identify the factors influencing the delivery outcome of women with scarred uterus. The receiver operating characteristic (ROC) curve analysis was used to evaluate the value of PDGF and the thickness of the myometrium in lower uterine segment in predicting the delivery outcome of women with scarred uterus who were planning to have another pregnancy. Results The age and the increase in gestational weight gain were both higher in the group with poor delivery outcome than those of the group with good outcome (P<0.05), while the time since the last cesarean section and the gestational age at delivery were lower in the group with poor delivery outcome than those of the group with good outcome (P<0.05). The PDGF level was higher in the poor delivery outcome group than that of the good outcome group (P<0.05), while the thickness of the lower uterine segment muscle wall was lower than that in the good outcome group (P<0.05). The results of Logistic regression analysis showed that older age, large increase in body weight during pregnancy and elevated PDGF levels were independent risk factors for adverse pregnancy outcomes in women with scarred uterus who were pregnant again (P<0.05), and the increase in the thickness of the muscular wall in the lower segment of the uterine was a protective factor (P<0.05). The ROC curve results showed that the area under the curve (AUC) for PDGF, the thickness of the myometrium in the lower uterine segment, and their combination in predicting the delivery outcome of women with scarred uterus who were pregnant again was 0.694 (95% CI: 0.586-0.802), 0.705 (95% CI: 0.604-0.807) and 0.893 (95% CI: 0.827-0.959), and the AUC predicted by the combination of the two was higher than that predicted by the individual indicators (P<0.05). Conclusion The increase in PDGF levels is a risk factor for poor pregnancy outcome in women with scarred uterus who are attempting another pregnancy, and the increase in the thickness of the uterine lower segment muscle wall is a protective factor. The combination of the two has a good predictive effect on the delivery outcome of pregnant women with a scarred uterus.

Key words: cicatrix, uterus, parturition, receptors, platelet-derived growth factor, lower uterine segment thickness

中图分类号:

R714

图/表 5

参考文献 23

[1]	施凤, 余韦. 3613例瘢痕子宫再次妊娠分娩结局分析[J]. 宁夏医科大学学报, 2023, 45(12):1272-1275.
	Shi F, Yu W. Outcome analysis of 3613 cases of second pregnancy with scarred uterus[J]. J Ningxia Med Univ, 2023, 45(12):1272-1275. doi:10.16050/j.cnki.issn1674-6309.2023.12.014.
[2]	Zhang Y, Zhang T, Liu X, et al. Research trends of pregnancy with scarred uterus after cesarean:a bibliometric analysis from 1999 to 2018[J]. J Matern Fetal Neonatal Med, 2022, 35(18):3555-3564. doi:10.1080/14767058.2020.1830368.
[3]	Meuleman S J M K, Murji A, Van Den Bosch T, et al. Definition and criteria for diagnosing cesarean scar disorder[J]. JAMA Netw Open, 2023, 6(3):e235321. doi:10.1001/jamanetworkopen.2023.5321.
[4]	Wang S, Zhu C, Su J, et al. Construction and application of a prediction model for the delivery outcome of women with scarred uterus based on ultrasonic parameters[J]. Am J Transl Res, 2023, 15(1):264-272.
[5]	Wang S, Hu Q, Liao H, et al. Perinatal outcomes of pregnancy in women with scarred uteri[J]. Int J Womens Health, 2023, 15:1453-1465. doi:10.2147/IJWH.S422187.
[6]	Kumar P, Mundkur A, Bhavna D S, et al. Intrauterine administration of autologous platelet-derived growth factor concentrate (aka autologous blood cell derivative) improves the endometrial thickness in 'thin' endometrium in the frozen embryo transfer cycle[J]. J Obstet Gynaecol India, 2023, 73(Suppl 1):108-114. doi:10.1007/s13224-022-01735-7.
[7]	Gao J, Song Y, Huang X, et al. The expression of platelet-derived growth factor,epidermal growth factor,and insulin-like growth factor-II in patients with polycystic ovary syndrome and its correlation with pregnancy outcomes[J]. Ann Palliat Med, 2021, 10(5):5671-5678. doi:10.21037/apm-21-1003.
[8]	郭婧, 郭颖, 罗晓华. 瘢痕子宫再次妊娠产妇成功阴道试产的影响因素分析[J]. 医药论坛杂志, 2021, 42(6):82-85.
	Guo J, Guo Y, Luo X H. Analysis of influencing factors on successful vaginal trial of labor in parturients with scarred uterus who are pregnant again[J]. Journal of Medical Forum, 2021, 42(6):82-85.
[9]	中华医学会妇产科学分会产科学组. 剖宫产术后再次妊娠阴道分娩管理的专家共识(2016)[J]. 中华妇产科杂志, 2016, 51(8):561-564.
	Obstetrics Group,Obstetrics and Gynecology Branch,Chinese Medical Association. Consensus of management of vaginal birth after cesarean (2016)[J]. Chin J Obstet Gynecol, 2016, 51(8):561-564. doi:10.3760/cma.j.issn.0529-567X.2016.08.001.
[10]	“高龄产妇妊娠期并发症防治策略研究”项目专家组. 高龄妇女瘢痕子宫再妊娠管理专家共识(2021年版)[J]. 中国实用妇科与产科杂志, 2021, 37(5):558-563.
	Expert Group of the Project "Research on Prevention and Treatment Strategies for Complications during Pregnancy in Elderly Parturients". Expert Consensus on the Management of Re-pregnancy in Elderly Women with Scarred Uterus (2021 Edition)[J]. Chinese Journal of Practical Gynecology and Obstetrics, 2021, 37(5):558-563. doi:10.19538/j.fk2021050114.
[11]	杨水莲. 妇产科学[M]. 武汉: 华中科技大学出版社, 2021:104-109.
	Yang S L. Obstetrics and gynecology[M]. Wuhan: Huazhong University of Science and Technology Publishing House, 2021:104-109.
[12]	Mcevoy A, Corbett G A, Nolan C, et al. Outcomes of uterine rupture in the setting of the unscarred compared with the scarred uterus[J]. Obstet Gynecol, 2023, 141(4):854-856. doi:10.1097/AOG.0000000000005108.
[13]	Taye L R, Basumatari B, Das M C, et al. Ultrasonographical evaluation of placenta previa in scarred and unscarred uterus in a tertiary care centre[J]. Cureus, 2023, 15(7):e42586. doi:10.7759/cureus.42586.
[14]	李凯, 王振东, 赵雪琴, 等. 血清VEGF-C、PDGF水平对瘢痕子宫产妇再次妊娠分娩结局的预测价值[J]. 分子诊断与治疗杂志, 2025, 17(7):1275-1277,1281.
	Li K, Wang Z D, Zhao X Q, et al. The predictive value of serum VEGF-C and PDGF levels for the delivery outcome of women with scarred uterus[J]. J Mol Diagn Ther, 2025, 17(7):1275-1277,1281. doi:10.3969/j.issn.1674-6929.2025.07.029.
[15]	Rashid F N, Clayton Z E, Ogawa M, et al. Platelet derived growth factor-A (PDGF-A) gene transfer modulates scar composition and improves left ventricular function after myocardial infarction[J]. Int J Cardiol, 2021, 341:24-30. doi:10.1016/j.ijcard.2021.07.021.
[16]	Park H, Seok J, You J H, et al. Increased phosphatase regenerating liver-1 trigger vascular remodeling in injured ovary via platelet-derived growth factor signaling pathway[J]. Stem Cell Res Ther, 2022, 13(1):95. doi:10.1186/s13287-022-02772-9.
[17]	Ross J L, Chen Z, Herting C J, et al. Platelet-derived growth factor beta is a potent inflammatory driver in paediatric high-grade glioma[J]. Brain, 2021, 144(1):53-69. doi:10.1093/brain/awaa382.
[18]	Debras E, Capmas P, Maudot C, et al. Uterine wound healing after caesarean section:a systematic review[J]. Eur J Obstet Gynecol Reprod Biol, 2024, 296:83-90. doi:10.1016/j.ejogrb.2024.02.045.
[19]	Hume R D, Deshmukh T, Doan T, et al. PDGF-AB reduces myofibroblast differentiation without increasing proliferation after myocardial infarction[J]. JACC Basic Transl Sci, 2023, 8(6):658-674. doi:10.1016/j.jacbts.2022.11.006.
[20]	高洁凡, 王东晖, 宋阳阳, 等. 血清IGFBP-3、PDGF及bFGF联合检测对多囊卵巢综合征患者妊娠结局的预测价值[J]. 中国现代医学杂志, 2023, 33(21):94-98.
	Gao J F, Wang D H, Song Y Y, et al. The predictive value of combined detection of serum IGFBP-3,PDGF and bFGF on pregnancy outcome in patients with polycystic ovary syndrome[J]. China Journal of Modern Medicine, 2023, 33(21):94-98. doi:10.3969/j.issn.1005-8982.2023.21.014.
[21]	Zhang L, Li T, Zhang P, et al. Analyzing influencing factors of uterine rupture in pregnant women with scarred uterus undergoing repeat delivery and evaluating the predictive value of lower uterine anterior wall thickness[J]. Int J Womens Health, 2025, 17:2421-2431. doi:10.2147/IJWH.S530520.
[22]	胡慧颖, 丁永霞. 瘢痕子宫再妊娠孕妇子宫肌层厚度与不良妊娠结局关系[J]. 中国计划生育学杂志, 2024, 32(2):417-420,426.
	Hu H Y, Ding Y X. Correlation between the muscular layer thickness of pregnant women with scarred uterus and their adverse pregnancy outcomes[J]. Chin J Fam Plann, 2024, 32(2):417-420,426. doi:10.3969/j.issn.1004-8189.2024.02.034.
[23]	朱燕霞, 刘群英, 王苓入. 腹部超声检测子宫前壁下段肌层厚度在瘢痕子宫再次妊娠分娩前的应用价值[J]. 医学影像学杂志, 2025, 35(4):102-105.
	Zhu Y X, Liu Q Y, Wang L R, et al. Application value of abdominal ultrasound in detecting the thickness of myometrium in the lower segment of the anterior uterine wall before delivery in repeated pregnancy of cesarean scar uterus[J]. J Med Imaging, 2025, 35(4):102-105. doi:10.20258/j.cnki.1006-9011.2025.04.025.

组别		n		年龄/岁		孕期体质量增加量/kg			妊娠次数					人工流产史			早产史			分娩次数
组别		n		年龄/岁		孕期体质量增加量/kg			≥2次			<2次		人工流产史			早产史			≥2次			<2次
结局良好组		132		33.24±1.96		14.24±2.01			47（35.61）			85（64.39）		60（45.45）			25（18.94）			41（31.06）			91（68.94）
结局不良组		64		34.01±2.14		15.36±2.18			29（45.31）			35（54.69）		36（56.25）			18（28.13）			24（37.50）			40（62.50）
t或χ²				2.502^＊		3.558^＊＊			1.711					2.010			2.124			0.806
组别			距上次剖宫产时间/年				孕期产检次数/次				临产入院				产前应用宫缩剂			分娩方式
组别			距上次剖宫产时间/年				孕期产检次数/次				临产入院				产前应用宫缩剂			阴道顺产			剖宫产
结局良好组			3.95±0.34				8.29±0.63				21（15.91）				21（15.91）			59（44.70）			73（55.30）
结局不良组			2.86±0.38				8.14±0.59				13（20.31）				14（21.88）			26（40.63）			38（59.38）
t或χ²			20.244^＊＊				1.595				0.583				1.046			0.291
组别	分娩孕周/周				新生儿体质量/kg			收缩压/mmHg		舒张压/mmHg			血糖/（mmol/L）			APTT/s			PT/s			D-D/（mg/L）
结局良好组	39.04±0.52				3.09±0.18			127.62±9.03		78.64±8.96			5.21±0.54			28.32±1.16			11.42±1.49			1.03±0.12
结局不良组	38.01±0.45				3.05±0.16			129.85±10.26		77.49±9.15			5.32±0.57			28.03±1.23			11.14±1.54			1.01±0.14
t	13.569^＊＊				1.511			1.550		0.837			1.313			1.609			1.220			1.035

组别		n		年龄/岁		孕期体质量增加量/kg			妊娠次数					人工流产史			早产史			分娩次数
组别		n		年龄/岁		孕期体质量增加量/kg			≥2次			<2次		人工流产史			早产史			≥2次			<2次
结局良好组		132		33.24±1.96		14.24±2.01			47（35.61）			85（64.39）		60（45.45）			25（18.94）			41（31.06）			91（68.94）
结局不良组		64		34.01±2.14		15.36±2.18			29（45.31）			35（54.69）		36（56.25）			18（28.13）			24（37.50）			40（62.50）
t或χ²				2.502^＊		3.558^＊＊			1.711					2.010			2.124			0.806
组别			距上次剖宫产时间/年				孕期产检次数/次				临产入院				产前应用宫缩剂			分娩方式
组别			距上次剖宫产时间/年				孕期产检次数/次				临产入院				产前应用宫缩剂			阴道顺产			剖宫产
结局良好组			3.95±0.34				8.29±0.63				21（15.91）				21（15.91）			59（44.70）			73（55.30）
结局不良组			2.86±0.38				8.14±0.59				13（20.31）				14（21.88）			26（40.63）			38（59.38）
t或χ²			20.244^＊＊				1.595				0.583				1.046			0.291
组别	分娩孕周/周				新生儿体质量/kg			收缩压/mmHg		舒张压/mmHg			血糖/（mmol/L）			APTT/s			PT/s			D-D/（mg/L）
结局良好组	39.04±0.52				3.09±0.18			127.62±9.03		78.64±8.96			5.21±0.54			28.32±1.16			11.42±1.49			1.03±0.12
结局不良组	38.01±0.45				3.05±0.16			129.85±10.26		77.49±9.15			5.32±0.57			28.03±1.23			11.14±1.54			1.01±0.14
t	13.569^＊＊				1.511			1.550		0.837			1.313			1.609			1.220			1.035

组别	n	PDGF/（ng/L）	子宫下段肌壁厚度/mm
结局良好组	132	39.14±4.86	3.29±0.34
结局不良组	64	45.08±5.01	2.86±0.32
t		7.944^＊＊	8.461^＊＊

组别	n	PDGF/（ng/L）	子宫下段肌壁厚度/mm
结局良好组	132	39.14±4.86	3.29±0.34
结局不良组	64	45.08±5.01	2.86±0.32
t		7.944^＊＊	8.461^＊＊

变量	β	SE	Wald χ²	P	OR	OR95%CI
年龄	1.128	0.332	11.540	<0.001	3.089	2.067~4.617
孕期体质量增加量	0.961	0.369	6.781	0.009	2.614	1.268~5.388
PDGF	1.014	0.216	22.044	<0.001	2.757	1.805~4.210
子宫下段肌壁厚度	-1.248	0.314	15.804	<0.001	0.287	0.155~0.531
距上次剖宫产时间	-2.235	1.621	1.901	0.168	0.107	0.004~2.566
分娩孕周	-2.154	1.181	3.327	0.068	0.116	0.011~1.174
常数项	-3.943	0.371	112.746	<0.001	0.019

血清PDGF与子宫下段肌壁厚度对瘢痕子宫再次妊娠分娩结局的预测价值

Predictive value of platelet-derived growth factor and lower uterine segment thickness for delivery outcome in pregnancy with a scarred uterus

引用本文

RichHTML

PDF (PC)

可视化

摘要/Abstract

使用本文

图/表 5

参考文献 23

相关文章 15

编辑推荐

Metrics

本文评价

变量	AUC	95%CI	最佳截断值	敏感度/%	特异度/%	约登指数
PDGF	0.694	0.586~0.802	42.09 ng/L	62.50	61.36	0.239
子宫下段肌壁厚度	0.705	0.604~0.807	3.08 mm	60.94	75.76	0.367
联合	0.893	0.827~0.959	—	89.06	89.39	0.785

[1]	刘甚红, 马媛媛, 张丽梅. IgE高亲和力受体结合NPC2对DNP-BSA诱导的肥大细胞脱颗粒和组胺释放的机制探讨[J]. 天津医药, 2026, 54(5): 455-461.
[2]	卢红霞, 郭燕军, 黄晗, 张婷. miR-421靶向MPP7/EGFR/AKT轴影响巨噬细胞M2极化改善哮喘小鼠的气道炎症[J]. 天津医药, 2026, 54(5): 462-468.
[3]	徐彤, 杨星旺, 刘永辉. Toll样受体激动剂及其在肿瘤疫苗中的应用研究进展[J]. 天津医药, 2026, 54(5): 550-555.
[4]	段程丽, 申彦杰, 郭丽霞, 王碧航, 俎晓霞, 刘玉强. 硬膜外镇痛产妇产时发热时刻和发热峰值对新生儿不良结局的交互作用分析[J]. 天津医药, 2026, 54(4): 364-368.
[5]	赵政委, 许文艳, 郭晓敏, 王敏, 李建丽, 李志海, 沈东琼, 涂云贵. 脓毒症患者血清LRG1、suPAR水平对并发急性肾损伤的预测价值[J]. 天津医药, 2026, 54(4): 374-378.
[6]	郭丽华, 滕丹, 陈亚东, 贾小玲, 宋艳丽. 通管汤保留灌肠联合热敏灸治疗气滞血瘀型输卵管性不孕症的临床疗效[J]. 天津医药, 2026, 54(4): 395-401.
[7]	冯小艳, 张文倩, 方自红, 张广辉. NRP-1和CXCR4对卵巢子宫内膜异位囊肿患者妊娠结局的预测价值[J]. 天津医药, 2026, 54(4): 402-406.
[8]	姜天佑, 李敏, 孙碧文, 李越洋, 邢丽静, 田晨. Let-7b诱导白血病相关巨噬细胞复极抑制AML的发展[J]. 天津医药, 2026, 54(3): 225-231.
[9]	李佳, 赵墨菊, 杨惠茹, 高丽峰, 高月, 李侃, 郭素娜, 沈建军. 超声引导下2种神经阻滞方法在腹腔镜全子宫切除术中麻醉效果与安全性比较[J]. 天津医药, 2026, 54(3): 264-268.
[10]	黄熷远, 付靖, 赵亚, 王龙灏, 仓顺东. 非小细胞肺癌EGFR-TKI耐药与p53基因突变的研究进展[J]. 天津医药, 2026, 54(3): 333-336.
[11]	于洋, 谷梦青. 女性生殖健康调控机制与研究进展[J]. 天津医药, 2026, 54(2): 113-116.
[12]	董昀澍, 潘恒, 牛红娟. 子宫内膜疾病与生殖道菌群及肠道菌群串扰的研究进展[J]. 天津医药, 2026, 54(2): 127-131.
[13]	王志景, 何全中. 携载木犀草苷的透明质酸钠水凝胶宫腔灌注对大鼠宫腔粘连的疗效观察[J]. 天津医药, 2026, 54(2): 164-168.
[14]	万艳波, 刘明, 王勇. 秦皮甲素调节HMGB1/RAGE信号通路对缺氧/复氧诱导的心肌细胞损伤的影响[J]. 天津医药, 2025, 53(8): 796-801.
[15]	王婷, 王丹, 李瑛. 血清自身抗体变化对不明原因复发性流产患者妊娠结局的影响及预测模型构建[J]. 天津医药, 2025, 53(8): 831-835.